We then evaluated OXT peptide levels in both the CSF (see Figure 3H) and serum (see Figure 3I), and found that prenatal MPA exposure significantly decreased OXT levels, and prenatal OXT deficiency achieved a further decrease. This evidence concerns the gene OXT and hyperinsulinemic hypoglycemia, familial, 4.